BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10542889)

  • 21. Clinical implication of medroxyprogesterone acetate against advanced ovarian carcinoma: a pilot study.
    Niwa K; Onogi K; Wu Y; Mori H; Harrigan RC; Tamaya T
    Eur J Gynaecol Oncol; 2008; 29(3):252-5. PubMed ID: 18592789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
    Sugiyama T; Yoshizaki A; Hatayama S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic surgical staging: stage I ovarian cancer.
    Piver MS
    J Clin Oncol; 1997 Feb; 15(2):864-5. PubMed ID: 9053518
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytoprotective effect of Amifostine in the combined chemotherapy of advanced ovarian carcinoma].
    Nagy P; Kádasi L
    Orv Hetil; 2000 Sep; 141(37):2027-30. PubMed ID: 11037611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
    Armstrong DK; Bundy B; Wenzel L; Huang HQ; Baergen R; Lele S; Copeland LJ; Walker JL; Burger RA;
    N Engl J Med; 2006 Jan; 354(1):34-43. PubMed ID: 16394300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage III-IV epithelial carcinoma of the ovary: is the second-look operation of any value for the patient?
    Atad J; Bornstein J; Steiner M; Weill S; Lurie M; Abramovici H
    Isr J Med Sci; 1988 Nov; 24(11):660-3. PubMed ID: 3215758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjuvant chemotherapy with cisplatin and cyclophosphamide in FIGO I-II epithelial carcinoma of the ovary: preliminary results].
    Chiara S; Conte PF; Bruzzone M; Falcone A; Rosso R; Ragni N; Bentivoglio G; Foglia G; Pescetto G
    G Ital Chemioter; 1985; 32(1):67-9. PubMed ID: 3830795
    [No Abstract]   [Full Text] [Related]  

  • 29. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stage III and IV epithelial cancer of the ovary. Prognostic role of surgical tumor reduction].
    Le Bouedec G; Ben Ahmed S; Plagne R; Dauplat J
    Presse Med; 1990 Mar; 19(11):506-10. PubMed ID: 2138748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ovarian carcinoma: pilot study of hyperthermic intraoperative peritoneal perfusion of antiblastic agents].
    Rossi CR; Pilati P; Mocellin S; Vaglini M; Deraco M; Lise M
    Tumori; 1999; 85(3 Suppl 1):S43-5. PubMed ID: 10542887
    [No Abstract]   [Full Text] [Related]  

  • 32. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
    Chiara S; Conte PF; Bruzzone M; Falcone A; Sertoli MR; Carnino F; Mossetti C; Iura R; Durando C; Guercio E
    Chemioterapia; 1987 Oct; 6(5):380-3. PubMed ID: 3427698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgery in the treatment concept of epithelial ovarian cancer].
    Salzer H; Genger H; Gober S; Barrada M; Vavra N; Sevelda P
    Gynakol Rundsch; 1990; 30 Suppl 1():26-9. PubMed ID: 2079293
    [No Abstract]   [Full Text] [Related]  

  • 34. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
    Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
    Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy in ovarian cancer.
    Park TW; Kuhn WC
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):639-47. PubMed ID: 15270667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of paclitaxel and cisplatin in a patient with epithelial ovarian cancer and human immunodeficiency virus.
    Knox SN; Robinson JB; Im DD; Logan L; Rosenshein NB
    Gynecol Oncol; 2000 Jan; 76(1):118-22. PubMed ID: 10620453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
    Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G
    Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinosarcoma of the ovary-a case series.
    Rutledge TL; Gold MA; McMeekin DS; Huh WK; Powell MA; Lewin SN; Mutch DG; Johnson GA; Walker JL; Mannel RS
    Gynecol Oncol; 2006 Jan; 100(1):128-32. PubMed ID: 16213011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The surgical treatment of ovarian cancer].
    Burghardt E; Lahousen M; Stettner H
    Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):670-7. PubMed ID: 2272432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol.
    Wong R; Milosevic M; Sturgeon J; Pintilie M; Fyles A; Levin W; Rosen B; Depetrillo D; Oza A; Manchul L; Murphy J; Chapman W
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):657-65. PubMed ID: 10524420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.